京都府立医科大学：Endocrine Surgery

Subject

Endocrine Surgery

Staff

Professor
Tetsuya Taguchi

Lecturer　　　　　　　　　　Koichi Sakaguchi

Assistant Professor　　　　　Yoshimi Ouchi, Midori Morita

Research Contents

Breast-conserving therapy : Immediate reconstruction with latissimus dorsi muscle flap
Breast-conserving therapy : Immediate reconstruction with silicone implant
Order-made therapy with molecular targeted drugs
Preoperative chemo therapy

Achievements

Taguchi T, Yamamoto D, Masuda N, Oda K, Nakayama T, Nagata T, Nomura M, Yoshidome K, Yoshino H, Matsunami N, Miyashita M, Furuya Y, Ishida T, Wakita K, Sakamoto J, Noguchi S; Kinki Breast Cancer Study Group (KBCSG). Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609.Cancer Chemother Phamacol. 2013 Mar;71(3):741-7.
Taguchi, T., Masuda, N., Nakayama, T., Motomura, K., Tsukamoto, F., Shimazu, K., Nomura, T., Morimoto, T., Yamamoto, H., Wakita, K., Nakano, Y., Yoneda, K., Inaji, H., Takatsuka Y. and Noguchi S. Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)]. Oncology 78(5-6):302-308 2010.
Taguchi, T., Nakayama, T., Masuda, N., Yoshidome, K., Akagi, K., Nishida, Y., Yoshikawa, Y., Ogino, N., Abe, C., Sakamoto, J., Noguchi, S., Kinki Breast Cancer Study Group. Study of Low-Dose Capecitabine Monotherapy for Metastatic Breast Cancer. Chemotherapy, 56(2):166–170, 2010.
Taguchi, T., Aihara, T., Takatsuka, Y., Shin, E., Motomura, K., Inaji, H., and Noguchi, S. Phase II study of weekly paclitaxel for docetaxel-resistant metastatic breast cancer in Japan. Breast J, 10: 509-513, 2004.

Contact

tel 81-75-251-5534
fax 81-75-251-0270
e-mail breast@koto.kpu-m.ac.jp